Aramco's Prosperity7 powers AI drug firm Insilico's $95M round
Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” The firm has raised $35 million on the heels of its last tranche in June, bringing its total Series D investment to $95 million.
Product updates: Rollbacks, batching, sandbox tunnels & moreModal
Product updates: Datadog integration, lower function latency & moreModal
Simulating Human Behavior with Cerebras - CerebrasCerebras
100x Defect Tolerance: How Cerebras Solved the Yield Problem - CerebrasCerebras
Cerebras Announces Six New AI Datacenters Across North America and Europe to Deliver Industry’sCerebras
Cerebras Systems, Ranovus win $45 million US military deal to speed up chip connectionsCerebras
Accelerating GPT-5.6 Sol UltrafastCerebras
Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of ArtificialCerebras
Speech-to-Text API model for Pharma Use Cases | Nova-3 PharmaDeepgram
Today We Start the Next Chapter of the Voice AI EconomyDeepgram
Product updates: Logs v2, live container profiling, and region selection on all plansModal
Product updates: Running batch jobs with 1M inputs, ephemeral apps, and a new TensorRT-LLM exampleModal
Product updates: Updates to Volumes, JS and Go SDKs, and moreModal
Product updates: Modal Notebooks, sandbox idle timeouts, and moreModal
